John E. Memmott
14Patents
5h-index
29Co-inventors
58Inventor score
Filing activity: Dec 28, 2007 → May 16, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8835610B2 | IL-17 binding proteins | Emerging Cross-Sectional Technologies | 28 | Active |
| US9663587B2 | IL-17 binding proteins | Emerging Cross-Sectional Technologies | 14 | Active |
| US8779101B2 | IL-17 binding proteins | Emerging Cross-Sectional Technologies | 11 | Active |
| US9102722B2 | Composition and method for the diagnosis and treatment of diseases associated with neurite degeneration | Physics | 5 | Active |
| US9655964B2 | Bispecific antibodies directed against TNF-α and IL-17 | Chemistry; Metallurgy | 5 | Active |
| US8999331B2 | Immunobinders directed against sclerostin | Chemistry; Metallurgy | 4 | Active |
| US9481735B2 | IL-17 binding proteins | Emerging Cross-Sectional Technologies | 3 | Active |
| US8324350B2 | Dual-specific IL-1α/IL-1β antibodies | Chemistry; Metallurgy | 3 | Active |
| US9481736B2 | IL-17 binding proteins | Emerging Cross-Sectional Technologies | 2 | Active |
| US8916504B2 | Methods of RNA display | Chemistry; Metallurgy | 2 | Active |
| US9803009B2 | Immunobinders directed against TNF | Chemistry; Metallurgy | 2 | Active |
| US9365643B2 | Antibodies that bind to repulsive guidance molecule A (RGMA) | Physics | 1 | Active |
| US10106602B2 | Isolated monoclonal anti-repulsive guidance molecule A antibodies and uses thereof | Physics | 1 | Active |
| US8404445B2 | Antibody libraries | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.